Loss of CDC14B Expression in Clear Cell Renal Cell Carcinoma: Meta-Analysis of Microarray Data Sets. Issue 4 (1st April 2014)

• Record Type: Journal Article
• Authors: Kim, Younghye; Choi, Jung-Woo; Lee, Ju-Han; Kim, Young-Sik
• Is Part Of: American journal of clinical pathology. Volume 141:Issue 4(2014)
• Page Start: 551
• Page End: 558
• Publication Date: 2014-04-01
• Subjects: Renal cell carcinoma -- Meta-analysis -- Microarray -- CDC14B; Diagnosis, Laboratory -- Periodicals; Pathology -- Periodicals; 616.07
• DOI: 10.1309/AJCP4PE4JPSRGBQS
• Languages: English
• ISSNs: 0002-9173

Abstract

Abstract: Objectives: To discover significant differentially expressed genes (DEGs) in clear cell renal cell carcinoma (ccRCC) that might be unidentified by single microarray analysis. Methods: The effect sizes of five ccRCC microarray data sets were combined using a random-effects model. The most downregulated gene was validated in paired 80 ccRCC tissues by immunohistochemistry. Results: CDC14B was the most downregulated gene among 1, 761 DEGs. CDC14B was strongly expressed in the apical proximal tubules in the nonneoplastic tissues, while it was completely absent in 10 (12.5%) of 80 or downregulated in 70 (87.5%) of 80 ccRCC cases. The complete loss of CDC14B correlated with high T stage (P = .038), advanced TNM stage (P = .027), tumor recurrence (P = .038), and shorter recurrence-free survival (P = .046) compared with the partial loss of CDC14B. Conclusions: Microarray meta-analysis is a useful tool for pathologists. CDC14B expression is downregulated in ccRCC, suggesting its role in renal carcinogenesis.